Shareable Research Card

TLYS - TILLY'S, INC. Operating Margin

This metric view shows TLYS - TILLY'S, INC. operating margin history from SEC company facts.

Use it to verify the latest reported value, compare nearby periods, and jump to a cross-company ranking when a curated insight exists.

Context
Latest reported period: Q3 2025
Latest reported value
-26%

Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Values may differ by reporting period and company taxonomy.

Return Loop

Why revisit this metric view

This metric history becomes more useful after the next quarterly or annual filing because the latest reported value, period, and company comparison context can all change.

Latest source-backed update
Latest period end 01 Nov 2025
Why come back
Return after the next filing to verify whether this metric changed and how it compares with the ranking page.
  • Current latest reported period: Q3 2025.
  • Latest reported value on this page: -26%.
  • Save this filer if you want to compare the next reported value with this history.

Metric freshness comes from the latest SEC company fact available for this taxonomy tag and the paired company facts page.

Latest update

Latest update for Operating Margin

New fact period available

Latest reported operating margin: -26%. Open the source-backed page to compare this metric with the newest filing-backed context.

Update date

01 Nov 2025

Page type

Metric history

Latest period

Q3 2025

SEC-backed company facts were refreshed from filings filed on 09 Apr 2026.

Benchmark Context

How Operating Margin compares with peers

TILLY'S, INC. is outside the visible top 120 companies for operating margin in the current sample.

Compared with

Compared with 120 companies reporting operating margin in %. This keeps the comparison on the same metric and unit family.

Why this is notable

This is about -0.1x the current sample midpoint. Operating Margin is up about 16% versus the comparable prior period.

  • Visible rows currently span reported period ends from 30 Jun 2011 to 31 Dec 2025.
  • Nearby companies in this sample: Global Warming Solutions, Inc. and NAMI Corp..
  • Peer rows use the latest valid value per company for this exact metric and compatible units.

Peer comparisons use the same metric and compatible units only. Latest reported periods may differ across companies, so open each company page before drawing conclusions.

Save this filer page

Create a free account to keep this page in your watchlists and return after a new SEC filing changes the record here.

Financial Metric Page

TILLY'S, INC.: Operating Margin

Latest period: Q3 2025. Period end: 01 Nov 2025. Units: %. Frequency: quarterly.

The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.

What This Metric Tells You

  • Shows the reported level of operating margin over 04 Aug 2018 - 01 Nov 2025.
  • Includes year-over-year change points to highlight acceleration or slowdown.
  • Built from 23 SEC fact rows for this metric and issuer.

How To Read This Chart

  • Start with the latest point, then compare it with the prior periods to see direction.
  • Use quarterly sequence to compare like-for-like periods.
  • Use YoY change bars to separate growth from contraction across matching periods.

Compare This Metric Across Companies

Compare latest available Operating Margin levels across SEC-reporting companies, then open each company metric page for SEC-backed verification. Reporting periods may differ by company.

Rank Company Latest value Reported period Next step
1 Global Warming Solutions, Inc. (gwso) 99905400% Quarter - 30 Sep 2022 Open Global Warming Solutions, Inc. Operating Margin
2 NAMI Corp. 1080289% Quarter - 31 Mar 2021 Open NAMI Corp. Operating Margin
3 PharmaCyte Biotech, Inc. (pmcb) 396584% Quarter - 31 Jan 2014 Open PharmaCyte Biotech, Inc. Operating Margin
4 ALR Technologies SG Ltd. (alrtf) 180380% Year - 31 Dec 2022 Open ALR Technologies SG Ltd. Operating Margin
5 MUSTANG BIO, INC. (mbio) 83624% Quarter - 30 Sep 2019 Open MUSTANG BIO, INC. Operating Margin
6 DOMINION ENERGY SOUTH CAROLINA, INC. 63100% Year - 31 Dec 2020 Open DOMINION ENERGY SOUTH CAROLINA, INC. Operating Margin

Metric Details

Metric
Operating Margin (OperatingMargin)
Taxonomy
ratio
Units tracked
%
Frequency coverage
quarterly
History range
04 Aug 2018 - 01 Nov 2025
Facts on this page
23
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Metric-level SEC endpoint
Open SEC company concept

Chart Context

Compare periods with the same frequency first, then use YoY and TTM series to confirm whether changes are structural or one-off.

Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Change (%)

TILLY'S, INC. Quarterly Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -26% +5% +16% 03 Aug 2025 01 Nov 2025
Q2 2025 -32% -12% -59% 04 May 2025 02 Aug 2025
Q1 2025 -48% -18% -61% 02 Feb 2025 03 May 2025
Q3 2024 -31% -16% -115% 04 Aug 2024 02 Nov 2024
Q2 2024 -20% -11% -114% 05 May 2024 03 Aug 2024
Q1 2024 -30% -24% -413% 04 Feb 2024 04 May 2024
Q3 2023 -14% -31% -185% 30 Jul 2023 28 Oct 2023
Q2 2023 -9.4% -41% -130% 30 Apr 2023 29 Jul 2023
Q1 2023 -5.8% -56% -111% 29 Jan 2023 29 Apr 2023
Q3 2022 17% -24% -59% 31 Jul 2022 29 Oct 2022
Q2 2022 31% +2% +7% 01 May 2022 30 Jul 2022
Q1 2022 51% +26% +105% 30 Jan 2022 30 Apr 2022
Q3 2021 41% +47% 01 Aug 2021 30 Oct 2021
Q2 2021 29% +32% 02 May 2021 31 Jul 2021
Q1 2021 25% +25% 31 Jan 2021 01 May 2021
Q3 2020 -6.2% -26% -131% 02 Aug 2020 31 Oct 2020
Q2 2020 -3.3% -22% -118% 03 May 2020 01 Aug 2020
Q1 2020 -0.12% -23% -101% 02 Feb 2020 02 May 2020
Q3 2019 20% -1.8% -8.4% 04 Aug 2019 02 Nov 2019
Q2 2019 18% -6.5% -26% 05 May 2019 03 Aug 2019
Q1 2019 23% 03 Feb 2019 04 May 2019
Q3 2018 22% 05 Aug 2018 03 Nov 2018
Q2 2018 25% 06 May 2018 04 Aug 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.